Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Rheumatology (Oxford, England)|May 15, 2025
Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacySaskia R Veldkamp, Maud Reugebrink, Sanne W Evers, et al.
Cytokine|May 4, 2021
Differential levels of IFNα subtypes in autoimmunity and viral infectionVincent Bondet, Mathieu P Rodero, Céline Posseme, et al.
The Journal of Allergy and Clinical Immunology|January 15, 2017
Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signalingIsabelle Melki, Yoann Rose, Carolina Uggenti, et al.
The Journal of Allergy and Clinical Immunology|July 28, 2023
Pathogenic variants in the NLRP3 LRR domain at position 861 are responsible for a boost-dependent atypical CAPS phenotypeAntoine Fayand, Margaux Cescato, Laurent Le Corre, et al.
Nature Communications|November 2, 2023
ARF1 prevents aberrant type I interferon induction by regulating STING activation and recyclingMaximilian Hirschenberger, Alice Lepelley, Ulrich Rupp, et al.
The Journal of Experimental Medicine|August 13, 2021
Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3AAlice Lepelley, Erika Della Mina, Erika Van Nieuwenhove, et al.
Rheumatology (Oxford, England)|October 17, 2025
IFN-α levels correlate with muscle disease activity only in juvenile dermatomyositis patients with anti-MDA5+ autoantibodiesThomas R J Moreau, Vincent Bondet, Saskia R Veldkamp, et al.
Rheumatology (Oxford, England)|November 23, 2019
Anti-MDA5 juvenile idiopathic inflammatory myopathy: a specific subgroup defined by differentially enhanced interferon-α signallingIsabelle Melki, Hervé Devilliers, Cyril Gitiaux, et al.
The Journal of Experimental Medicine|August 26, 2018
Life-threatening influenza pneumonitis in a child with inherited IRF9 deficiencyNicholas Hernandez, Isabelle Melki, Huie Jing, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2023
Successful treatment of JAK1-associated inflammatory diseaseAntoine Fayand, Véronique Hentgen, Céline Posseme, et al.
Pageof 5